Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial

BACKGROUND: Although safety and tolerability of vericiguat were established in the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) trial in patients with heart failure with reduced ejection fraction, some subgroups may be more susceptible to symptomat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Carolyn S. P., Mulder, Hillary, Lopatin, Yuri, Vazquez‐Tanus, Jose B., Siu, David, Ezekowitz, Justin, Pieske, Burkert, O’Connor, Christopher M., Roessig, Lothar, Patel, Mahesh J., Anstrom, Kevin J., Hernandez, Adrian F., Armstrong, Paul W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751950/
https://www.ncbi.nlm.nih.gov/pubmed/34743540
http://dx.doi.org/10.1161/JAHA.121.021094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751950/
https://www.ncbi.nlm.nih.gov/pubmed/34743540
http://dx.doi.org/10.1161/JAHA.121.021094

Ejemplares similares